Abdul Mannan: Breaking Down the New BSH Hepatitis Guideline for Haemophilia Nurses
Abdul Mannan, Consultant Haematologist, Director Haemophilia Centre, Haematology Lab Lead at Betsi Cadwaladr University Health Board shared a post on LinkedIn:
”Haemophilia nurses asked me to explain the new BSH hepatitis guideline. It’s 9 pages of dense clinical recommendations.
So I broke it down.
The guideline addresses a painful reality. Over 2,295 people with bleeding disorders in the UK were infected with hepatitis C through contaminated blood products in the 1970s-1990s. Many are our patients today.
I created a simplified learning resource for Band 7 nurses covering what they actually need to do:
Who to screen: anyone who received blood/plasma products before 1996
What tests to order: HBsAg, anti-HBs, anti-HBc, HCV antibody, and reflex HCV-RNA if positive
When to refer: active HBV/HCV infection goes straight to hepatology, F3/F4 fibrosis needs surveillance discussion
How to assess fibrosis: FibroScan is best, but FIB-4 score works if imaging isn’t available
The trickiest part? Deciding who needs long-term HCC surveillance after HCV treatment. The guideline gives clear pathways based on historical fibrosis staging.
I included worked examples, practical scenarios, and a step-by-step walkthrough of the follow-up algorithm. Clinical guidelines work better when nurses can actually use them.
Published in British Journal of Haematology, January 2025․՛
Access the full learning resource here: Hepatitis B & C Management in Bleeding Disorders – A Learning Resource for Haemophilia Nurses․”
Title: Guideline for the management of hepatitis B and C infection and subsequent liver disease surveillance (where indicated) in people with congenital bleeding disorders: A joint guideline from the British Society of Haematology and the British Viral Hepatitis Group
Authors: Ashley Brown, Richard J. Aspinall, Stephen T. Barclay, Mark Gillyon-Powell, Katie Jeffery, Patrick T. Kennedy, Neil McDougall, Tom Pembroke, Martin Scott, Susan Shapiro
Read the Full Article on British Journal of Haematology.
More posts from Dr Abdul Mannan on Hemostasis Today.
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs